CN113336749A - Preparation method of indoloquinoline compound - Google Patents

Preparation method of indoloquinoline compound Download PDF

Info

Publication number
CN113336749A
CN113336749A CN202110572773.7A CN202110572773A CN113336749A CN 113336749 A CN113336749 A CN 113336749A CN 202110572773 A CN202110572773 A CN 202110572773A CN 113336749 A CN113336749 A CN 113336749A
Authority
CN
China
Prior art keywords
compound
indoloquinoline
preparation
reactor
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110572773.7A
Other languages
Chinese (zh)
Other versions
CN113336749B (en
Inventor
张谦
解琳
杨鹏
李栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUHAN INNERSE PHARMACEUTICAL Inc
Original Assignee
Hubei University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University of Technology filed Critical Hubei University of Technology
Priority to CN202110572773.7A priority Critical patent/CN113336749B/en
Publication of CN113336749A publication Critical patent/CN113336749A/en
Application granted granted Critical
Publication of CN113336749B publication Critical patent/CN113336749B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a preparation method of an indoloquinoline compound, which comprises the steps of adding a compound I, a catalyst iodine simple substance, an organic solvent and a magneton into a reactor, placing the reactor into an oil bath kettle at 70-90 ℃, heating, stirring, reacting for 6-10 hours, terminating the reaction, and purifying the product to obtain the indoloquinoline compound; wherein the first compound is o-aminostyrene or 3-methyl-6-vinylaniline. The method has mild reaction conditions, high yield and environmental friendliness; has certain bioactivity, and can be used in the fields of medicine, pesticide and paint dye synthesis.

Description

Preparation method of indoloquinoline compound
Technical Field
The invention relates to the technical field of heterocyclic compound synthesis, in particular to a preparation method of an indoloquinoline compound.
Background
Indole-containing heterocyclic compounds are important chemical intermediates and products, and the compounds are widely found in a plurality of important natural products. In recent years, indoloquinoline compounds have received wide attention as DNA intercalators and excellent antimalarial properties. The roots of ivy are often used for malaria treatment because of the high amount of ivy (an indoloquinoline compound). However, the prior art does not have a reliable preparation method of the indoloquinoline compound.
Disclosure of Invention
The invention aims to provide a preparation method of an indoloquinoline compound, which has simple process, mild reaction and environmental protection.
The scheme adopted by the invention is as follows:
adding a compound I, a catalyst iodine simple substance, an organic solvent and a magneton into a reactor, placing the reactor into an oil bath kettle at 70-90 ℃, heating, stirring, reacting for 6-10 hours, terminating the reaction, and purifying the product to obtain the indoloquinoline compound; the reaction formula is as follows:
Figure BDA0003083317970000011
the first compound is o-aminostyrene or 3-methyl-6-vinylaniline.
Preferably, the dosage ratio of the compound I, the elementary iodine and the organic solvent is (0.2-10) mmol: (0.1-5) mmol: (2-50) ml.
Preferably, the organic solvent is dimethylsulfoxide solution.
Preferably, the bottom end of the reactor is immersed in a silicone oil bath, the height of the silicone oil being higher than the liquid level in the reactor.
Preferably, the purity of the iodine is not lower than 99.5%; the purity of the organic solvent is not less than 99.5%.
Preferably, the rotation speed of the magnetic stirring is 100-600 r/s.
Preferably, it is characterized in that the way of terminating the reaction is by adding water.
Preferably, the purification mode is extraction by using an organic solvent, the obtained organic phases are combined, a crude product is obtained by reduced pressure distillation, and the indoloquinoline compound is obtained by column chromatography separation and purification.
The invention also aims to provide an indoloquinoline compound prepared by the method.
The invention also aims to provide application of the indoloquinoline compound in the fields of medicine synthesis, pesticide synthesis and paint dye synthesis.
The invention uses the iodine simple substance as the catalyst, and bimolecular o-aminostyrene directly reacts to generate the required indoloquinoline compound, thereby ensuring the green, high-efficiency and high atom economy of the reaction. Mild reaction conditions, high selectivity, high yield and environmental protection. The synthesized indoloquinoline compound has certain bioactivity and can be applied to the fields of medicine synthesis, pesticide synthesis, paint dye synthesis and the like.
Detailed Description
The following examples are provided to further illustrate the present invention for better understanding, but the present invention is not limited to the following examples.
Example 1 preparation of 11-methyl-6-H-indole [2,3-b ] quinoline:
Figure BDA0003083317970000021
0.2mmol of o-aminostyrene and 50 mol% of catalyst I are added22mL of dimethyl sulfoxide solution and magneton. The reactor was placed in an oil bath at 70-90 ℃ for 8 hours. Pouring the reaction solution into a separating funnel, adding 15mL of distilled water, extracting for 3 times by using 10mL of ethyl acetate, combining the obtained organic phases, performing spin-drying by using a rotary evaporator, and separating and purifying the crude product by using column chromatography to obtain the 11-methyl-6-H-indole [2,3-b ]]Quinoline 18.8mg, as a yellow solid, yield 72%.
By hydrogen nuclear magnetic resonance1H NMR(400MHz,CDCl3):δ3.23(s,3H),7.29-7.33(m,1H),7.52-7.55(m,3H),7.75-7.79(m,1H),8.16(d,J=8.93Hz,1H),8.27-8.30(m,2H),10.82(s,1H);13C NMR(100MHz,CDCl3):δ15.3,110.8,117.1,120.1,122.0,122.8,123.7,124.2,124.2,127.2,127.5,128.8,139.6,141.1,146.1,152.9。
Example 2 preparation of 3,8, 11-trimethyl-6-H-indol [2,3-b ] quinoline
Figure BDA0003083317970000022
Adding 0.2mmol 3-methyl-6-vinyl aniline and 50 mol% of catalyst I22mL of dimethyl sulfoxide solution andone for magneton number 5. The reactor was placed in an oil bath at 70-90 ℃ for 8 hours. Pouring the reaction solution into a separating funnel, adding 15mL of distilled water, extracting for 3 times by using 10mL of ethyl acetate, combining the obtained organic phases, drying by a rotary evaporator, and separating and purifying the crude product by column chromatography to obtain the 3,8, 11-trimethyl-6-H-indole [2,3-b ]]Quinoline 16.9mg, as a yellow solid, 65% yield.
By hydrogen nuclear magnetic resonance1H NMR(400MHz,(CD3)2SO):δ2.49(s,3H),2.54(s,3H),3.11(s,3H),7.08(dd,J=7.96Hz,J=0.58Hz,1H),7.26(s,1H),7.32(dd,J=8.61Hz,J=1.65Hz,1H),7.72(s,1H),8.17(dd,J=18.29Hz,J=8.30Hz,2H),11.55(s,1H);13C NMR(100MHz,(CD3)2SO):δ15.26,21.8,22.2,111.3,115.9,119.3,121.3,122.1,123.6,124.5,125.0,127.0,137.5,138.0,138.3,142.0,146.7,153.1.
While the foregoing is directed to the preferred embodiment of the present invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.

Claims (10)

1. The preparation method of the indoloquinoline compound is characterized in that a compound I, a catalyst iodine simple substance, an organic solvent and a magneton are added into a reactor, the reactor is placed in an oil bath kettle at 70-90 ℃ to be heated and stirred for reaction for 6-10 hours, the reaction is terminated, and the product is purified to obtain the indoloquinoline compound; the reaction formula is as follows:
Figure FDA0003083317960000011
the first compound is o-aminostyrene or 3-methyl-6-vinylaniline.
2. The preparation method according to claim 1, wherein the ratio of the first compound, the elemental iodine and the organic solvent is (0.2-10) mmol: (0.1-5) mmol: (2-50) ml.
3. The method according to claim 1, wherein the organic solvent is a dimethylsulfoxide solution.
4. The method according to claim 1, wherein the bottom end of the reactor is immersed in a silicone oil bath, and the height of the silicone oil is higher than the liquid level in the reactor.
5. The preparation method according to claim 1, wherein the purity of the iodine is not less than 99.5%; the purity of the organic solvent is not less than 99.5%.
6. The method of claim 1, wherein: the magnetic stirring speed is 100-600 rpm.
7. The process according to claim 1, wherein the reaction is terminated by adding water.
8. The preparation method according to claim 1, wherein the purification method comprises extracting with an organic solvent, combining the obtained organic phases, distilling under reduced pressure to obtain a crude product, and separating and purifying by column chromatography to obtain the indoloquinoline compounds.
9. An indoloquinoline compound characterized by being prepared by the method according to any one of claims 1 to 8.
10. The use of the indoloquinoline compound of claim 9 in the fields of drug synthesis, pesticide synthesis, and paint dye synthesis.
CN202110572773.7A 2021-05-25 2021-05-25 Preparation method of indoloquinoline compound Active CN113336749B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110572773.7A CN113336749B (en) 2021-05-25 2021-05-25 Preparation method of indoloquinoline compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110572773.7A CN113336749B (en) 2021-05-25 2021-05-25 Preparation method of indoloquinoline compound

Publications (2)

Publication Number Publication Date
CN113336749A true CN113336749A (en) 2021-09-03
CN113336749B CN113336749B (en) 2022-04-29

Family

ID=77471349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110572773.7A Active CN113336749B (en) 2021-05-25 2021-05-25 Preparation method of indoloquinoline compound

Country Status (1)

Country Link
CN (1) CN113336749B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114232013A (en) * 2021-11-12 2022-03-25 华南理工大学 Method for synthesizing indoloquinoline compound under electrochemical condition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103497211A (en) * 2013-10-15 2014-01-08 中国海洋大学 Indoloquinoline derivative and preparation method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103497211A (en) * 2013-10-15 2014-01-08 中国海洋大学 Indoloquinoline derivative and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAZUHIRO KOBAYASHI ET AL.: "1H-indole Derivatives by Iodine-Mediated Cyclization of 2-(Arylamino)styrene Derivatives", 《BULL. CHEM. SOC. JPN.》 *
SHAUKAT ALI ET AL.: "One-Pot Access to Indolo[2,3-b]quinolines by Electrophile-Triggered Cross-Amination/Friedel−Crafts Alkylation of Indoles with 1-(2-Tosylaminophenyl)ketones", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114232013A (en) * 2021-11-12 2022-03-25 华南理工大学 Method for synthesizing indoloquinoline compound under electrochemical condition

Also Published As

Publication number Publication date
CN113336749B (en) 2022-04-29

Similar Documents

Publication Publication Date Title
CN111606820B (en) Preparation method of N-iodobenzene-N-phenylamide compound
CN111646917B (en) Preparation method of iodobenzene para-amination compound promoted by m-chloroperoxybenzoic acid
CN104744303B (en) Bromomethylbiphenyls of 2 R 4 ' and preparation method thereof
CN113336749B (en) Preparation method of indoloquinoline compound
CN113666883B (en) Method for synthesizing 4-vinyl isoxazole derivative
CN113072489A (en) Preparation method of nitrogen heteroaromatic ring formamide compound
CN113336665B (en) Preparation method of bromobenzene para-aminated compound mediated by high-valence iodine reagent
CN111995554A (en) Method for preparing asymmetric organic selenium ether compound by metal-free chemical oxidation method
CN113248396B (en) Preparation method of chlorobenzene para-aminated compound mediated by high-valence iodine reagent
CN109456221A (en) A kind of synthetic method of acetanilide derivative
CN108383754B (en) Preparation method and application of aryl oxime ester compound
CN111606876A (en) Method for preparing 2- (2-oxo-2-phenethyloxy) isobenzyl-1, 3-diketone
CN108929251B (en) Method for direct trifluoromethylation of C (sp3) -H
CN110590621B (en) Method for synthesizing 1, 2-bis (arylsulfonyl) ethylene derivative by copper-catalyzed terminal alkyne
CN108191736B (en) 2, 3-disubstituted indole derivatives and preparation method thereof
CN113173859A (en) Method for synthesizing chiral alpha-amino alcohol compound
CN111606895B (en) Synthesis method of 1-alkyl-isoquinoline compound
CN110746337B (en) Synthesis method of 1-methyl-2-cyano-3-aliphatic substituted azole compound
CN113336677B (en) Synthesis method of aryl siloxane amination reaction
CN115819207B (en) Method for synthesizing 1, 1-disubstituted diene by nickel catalysis
CN113264880B (en) Preparation method of 4-halogenated isoquinoline compound
CN115677609B (en) Method for cyclizing and cyanating allyl phenyl carbamate derivative
CN115594604B (en) Preparation method of C14-labeled complex carboxylic acid
CN113264818B (en) Method for carbon-carbon cross-coupling reaction of quinone compound and alcohol under catalysis of silver
CN113773221A (en) P-benzoquinone compound and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20240823

Address after: 430073 No. 666, Gaoxin Avenue, East Lake Development Zone, Wuhan, Hubei Province

Patentee after: WUHAN INNERSE PHARMACEUTICAL Inc.

Country or region after: China

Address before: 430068 No. 28 Nanli Road, Hongshan District, Wuhan City, Hubei Province

Patentee before: HUBEI University OF TECHNOLOGY

Country or region before: China

TR01 Transfer of patent right